Literature DB >> 17049055

The role of hyaluronan degradation products as innate alloimmune agonists.

B M Tesar1, D Jiang, J Liang, S M Palmer, P W Noble, D R Goldstein.   

Abstract

Dendritic cells (DCs) play a key role in initiating alloimmunity yet the substances that activate them during the host response to transplantation remain elusive. In this study we examined the potential roles of endogenous innate immune agonists in activating dendritic cell-dependent alloimmunity. Using a murine in vitro culture system, we show that 135 KDa fragments of the extracellular matrix glycosaminoglycan hyaluronan induce dendritic cell maturation and initiate alloimmunity. Priming of alloimmunity by hyaluronan-activated DCs was dependent on signaling via TIR-associated protein, a Toll-like receptor (TLR) adaptor downstream of TLRs 2 and 4. However, this effect was independent of alternate TLR adaptors, MyD88 or Trif. Using an in vivo murine transplant model, we show that hyaluronan accumulated during skin transplant rejection. Examination of human lung transplant recipients demonstrated that increased levels of intragraft hyaluronan were associated with bronchiolitis obliterans syndrome. In conclusion, our study suggests that fragments of hyaluronan can act as innate immune agonists that activate alloimmunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17049055     DOI: 10.1111/j.1600-6143.2006.01537.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  86 in total

1.  Cytokine binding by polysaccharide-antibody conjugates.

Authors:  Liang Tso Sun; Kyle S Buchholz; Michael T Lotze; Newell R Washburn
Journal:  Mol Pharm       Date:  2010-09-01       Impact factor: 4.939

Review 2.  The innate immune system in allograft rejection and tolerance.

Authors:  David F LaRosa; Adeeb H Rahman; Laurence A Turka
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

3.  IL-6 and TNF-alpha synergistically inhibit allograft acceptance.

Authors:  Hua Shen; Daniel R Goldstein
Journal:  J Am Soc Nephrol       Date:  2009-04-08       Impact factor: 10.121

Review 4.  Inflammation and transplantation tolerance.

Authors:  Daniel R Goldstein
Journal:  Semin Immunopathol       Date:  2011-02-18       Impact factor: 9.623

5.  Synergistic activation of Toll-like receptor 8 by two RNA degradation products.

Authors:  Matthias Geyer; Karin Pelka; Eicke Latz
Journal:  Nat Struct Mol Biol       Date:  2015-02       Impact factor: 15.369

6.  Contribution of Toll-like receptor activation to lung damage after donor brain death.

Authors:  Anthony J Rostron; David M W Cork; Vassilios S Avlonitis; Andrew J Fisher; John H Dark; John A Kirby
Journal:  Transplantation       Date:  2010-10-15       Impact factor: 4.939

7.  Alloimmune lung injury induced by local innate immune activation through inhaled lipopolysaccharide.

Authors:  Stavros Garantziotis; Scott M Palmer; Laurie D Snyder; Tonya Ganous; Benny J Chen; Tie Wang; Donald N Cook; David A Schwartz
Journal:  Transplantation       Date:  2007-10-27       Impact factor: 4.939

Review 8.  Immunobiology of chronic lung allograft dysfunction: new insights from the bench and beyond.

Authors:  R A Shilling; D S Wilkes
Journal:  Am J Transplant       Date:  2009-06-10       Impact factor: 8.086

Review 9.  Innate immunity and organ transplantation: focus on lung transplantation.

Authors:  Daniel Kreisel; Daniel R Goldstein
Journal:  Transpl Int       Date:  2012-08-21       Impact factor: 3.782

Review 10.  Mechanism of cellular rejection in transplantation.

Authors:  Elizabeth Ingulli
Journal:  Pediatr Nephrol       Date:  2010-01       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.